thiazoles has been researched along with Urinary Retention in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Cheon, J; Kang, SG; Kang, SH; Lee, JG; Noh, TI; Shim, JS | 1 |
| Al-Shukri, S; Barkin, J; Drake, MJ; Fianu-Jonasson, A; Herschorn, S; Huang, M; MacDiarmid, S; Siddiqui, E; Stoelzel, M | 1 |
| Blauwet, MB; Chapple, CR; Huang, M; Kaplan, SA; Khullar, V; Mitcheson, D; Siddiqui, E | 1 |
| Kato, D; Kuroishi, K; Nozawa, Y; Tabuchi, H | 1 |
| Borg, J; Crook, J; Ma, C; Patil, N; Pond, G; Wallace, K; Zhou, D | 1 |
| Chapple, CR; Cummings, J; Dorrepaal, C; Drogendijk, T; Kaplan, SA; Klecka, J; Martin, N; Mitcheson, D | 1 |
| Bozikas, VP; Fokas, K; Garyfallos, G; Giouzepas, J; Nikolaidis, N; Xomalis, D | 1 |
| Chua, SE; Chung, AK | 1 |
| Certa, K; Chism, LM; Mago, R; Pinninti, NR | 1 |
3 trial(s) available for thiazoles and Urinary Retention
| Article | Year |
|---|---|
Mirabegron 50 mg once-daily for the treatment of symptoms of overactive bladder: an overview of efficacy and tolerability over 12 weeks and 1 year.
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Aged; Benzhydryl Compounds; Cresols; Double-Blind Method; Drug Administration Schedule; Female; Headache; Humans; Hypertension; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Thiazoles; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Retention; Urinary Tract Infections; Urination; Xerostomia | 2014 |
A phase III randomized trial of the timing of meloxicam with iodine-125 prostate brachytherapy.
Topics: Administration, Oral; Aged; Anti-Inflammatory Agents, Non-Steroidal; Brachytherapy; Cyclooxygenase 2 Inhibitors; Drug Administration Schedule; Edema; Humans; Iodine Radioisotopes; Male; Meloxicam; Middle Aged; Ontario; Prostatic Diseases; Thiazines; Thiazoles; Urinary Retention | 2010 |
Randomized double-blind, active-controlled phase 3 study to assess 12-month safety and efficacy of mirabegron, a β(3)-adrenoceptor agonist, in overactive bladder.
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Aged; Benzhydryl Compounds; Constipation; Cresols; Delayed-Action Preparations; Double-Blind Method; Female; Headache; Humans; Hypertension; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Single-Blind Method; Thiazoles; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Urinary Retention; Xerostomia | 2013 |
6 other study(ies) available for thiazoles and Urinary Retention
| Article | Year |
|---|---|
Effects of β3-adrenoceptor agonist on acute urinary retention in a rat model.
Topics: Acetanilides; Acute Disease; Adrenergic beta-3 Receptor Agonists; Animals; Disease Models, Animal; Rats; Rats, Sprague-Dawley; Thiazoles; Urinary Retention | 2021 |
Adding Mirabegron to Solifenacin to Treat Overactive Bladder Has Little Impact on Postvoid Residual Volume or Urinary Retention Risk.
Topics: Acetanilides; Adult; Aged; Aged, 80 and over; Catheterization; Cohort Studies; Female; Humans; Incidence; Male; Middle Aged; Muscarinic Antagonists; Prostatic Diseases; Randomized Controlled Trials as Topic; Residual Volume; Risk; Solifenacin Succinate; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive; Urinary Retention; Urodynamics; Urological Agents | 2017 |
Safety and Effectiveness of Mirabegron in Patients with Overactive Bladder in a Real-World Clinical Setting: A Japanese Post-Marketing Study.
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Adult; Aged; Aged, 80 and over; Diabetes Complications; Drug Administration Schedule; Female; Humans; Hypertension; Male; Middle Aged; Product Surveillance, Postmarketing; Prostatic Hyperplasia; Quality of Life; Severity of Illness Index; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive; Urinary Retention; Urological Agents | 2018 |
Urinary hesitancy and retention caused by ziprasidone.
Topics: Adult; Antipsychotic Agents; Humans; Male; Piperazines; Schizophrenia; Thiazoles; Urinary Retention | 2006 |
Acute urinary retention associated with selective serotonin reuptake inhibitors and ziprasidone.
Topics: Acute Disease; Antipsychotic Agents; Depressive Disorder, Major; Drug Monitoring; Electroconvulsive Therapy; Humans; Male; Middle Aged; Piperazines; Receptors, Serotonin, 5-HT2; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Thiazoles; Urinary Catheterization; Urinary Retention | 2007 |
Urinary retention associated with ziprasidone: a case report.
Topics: Antipsychotic Agents; Diagnostic and Statistical Manual of Mental Disorders; Efferent Pathways; Female; Humans; Middle Aged; Muscle Contraction; Muscle, Smooth; Piperazines; Psychotic Disorders; Raphe Nuclei; Thiazoles; Urinary Bladder; Urinary Retention | 2008 |